Invention Grant
- Patent Title: Anticoagulation fluid comprising citrate and phosphate
-
Application No.: US16576301Application Date: 2019-09-19
-
Publication No.: US11026968B2Publication Date: 2021-06-08
- Inventor: Jan Sternby , Anders Wieslander
- Applicant: GAMBRO LUNDIA AB
- Applicant Address: SE Lund
- Assignee: GAMBRO LUNDIA AB
- Current Assignee: GAMBRO LUNDIA AB
- Current Assignee Address: SE Lund
- Agency: K&L Gates LLP
- Priority: SE1350533-4 20130430,SE1350534-2 20130430
- Main IPC: A61K33/42
- IPC: A61K33/42 ; A61K33/00 ; A61K9/08 ; A61K31/7004 ; A61K31/194 ; A61K33/06 ; A61K9/00 ; A61K33/10 ; A61K33/14 ; A61M1/16
Abstract:
The present invention concerns an anticoagulation fluid comprising 10-40 mM citrate and 0.1-4 mM phosphate. The anticoagulation fluid is to be used for regional citrate anticoagulation in an extracorporeal blood circuit. The anticoagulation fluid may be combined with at least one treatment fluid in a dialysis treatment, and it may be included in a system for regional citrate anticoagulation in an extracorporeal blood circuit.
Public/Granted literature
- US20200009186A1 ANTICOAGULATION FLUID COMPRISING CITRATE AND PHOSPHATE Public/Granted day:2020-01-09
Information query
